...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Patient Enrollment Modeling

One more tidbit of info for BETonMACE vs. EXAMINE AND ELIXA. The median time from ACS event to randomization in study is 34 days, 45 days and ~60 days, respectively, for BETonMACE, EXAMINE and ELIXA. More evidence of BETonMACE patients having super high residual risk.

BDAZ

Share
New Message
Please login to post a reply